Back

Increased reluctant vesicles underlie synaptic depression by GPR55 in axon terminals of cerebellar Purkinje cells

Inoshita, T.; Kawaguchi, S.-y.

2026-01-20 neuroscience
10.1101/2024.11.25.625205 bioRxiv
Show abstract

Control of synaptic transmission efficacy by neuronal activity and neuromodulators is pivotal for brain function. Synaptic suppression by cannabinoids activating CB1 receptors has been extensively studied at the molecular and cellular levels to understand the neuronal basis for effects of cannabis intake. Here, we focused on GPR55, non-canonical type of cannabinoid receptor, which shows sensitivity to cannabidiol included in cannabis, aiming to highlight its actions on presynaptic function. Taking advantage of direct patch-clamp recordings from axon terminals of cerebellar Purkinje cells together with fluorescent imaging of vesicular exocytosis using synapto-pHluorin, we show that GPR55 suppresses synaptic transmission as CB1 receptor does, but through a distinct presynaptic modulation of release machinery. Activation of GPR55 reduced transmitter release by changing neither presynaptic action potential waveform nor Ca2+ influx, but by making a large population of Ca2+-responsive synaptic vesicles insensitive to Ca2+ influx through voltage-gated Ca2+ channels, leading to substantial reduction of the readily releasable pool of vesicles. Thus, the present study identifies a unique mechanism to suppress presynaptic transmitter release by an atypical cannabinoid receptor GPR55, which would enable subtype-specific modulation of neuronal computation by cannabinoid receptors.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

1
Neuropsychopharmacology
134 papers in training set
Top 0.4%
6.9%
2
eLife
5422 papers in training set
Top 11%
6.9%
3
The Journal of Neuroscience
928 papers in training set
Top 2%
6.4%
4
eneuro
389 papers in training set
Top 1%
6.4%
5
British Journal of Pharmacology
34 papers in training set
Top 0.1%
4.9%
6
ACS Chemical Neuroscience
60 papers in training set
Top 0.4%
4.2%
7
Neuropharmacology
60 papers in training set
Top 0.2%
4.0%
8
International Journal of Molecular Sciences
453 papers in training set
Top 2%
3.7%
9
Neuroscience
88 papers in training set
Top 0.4%
2.9%
10
Scientific Reports
3102 papers in training set
Top 44%
2.8%
11
Translational Psychiatry
219 papers in training set
Top 2%
2.8%
50% of probability mass above
12
Brain Research
35 papers in training set
Top 0.4%
2.4%
13
Frontiers in Molecular Neuroscience
43 papers in training set
Top 0.2%
2.1%
14
Cell Reports
1338 papers in training set
Top 20%
2.1%
15
Molecular Psychiatry
242 papers in training set
Top 2%
1.8%
16
Progress in Neurobiology
41 papers in training set
Top 0.7%
1.7%
17
iScience
1063 papers in training set
Top 14%
1.7%
18
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 4%
1.7%
19
Frontiers in Neuroscience
223 papers in training set
Top 4%
1.7%
20
Nature Communications
4913 papers in training set
Top 56%
1.2%
21
Journal of Neurochemistry
50 papers in training set
Top 0.3%
1.2%
22
Cellular and Molecular Life Sciences
84 papers in training set
Top 0.4%
1.1%
23
Molecular Neurobiology
50 papers in training set
Top 0.7%
1.0%
24
Pharmacological Research
15 papers in training set
Top 0.1%
1.0%
25
Cells
232 papers in training set
Top 5%
0.9%
26
Biochemical Pharmacology
18 papers in training set
Top 0.1%
0.9%
27
Frontiers in Pharmacology
100 papers in training set
Top 4%
0.9%
28
Molecular and Cellular Neuroscience
18 papers in training set
Top 0.5%
0.8%
29
Brain Sciences
52 papers in training set
Top 2%
0.8%
30
Communications Biology
886 papers in training set
Top 23%
0.8%